Navigation Links
BioRestorative Therapies Enters Into Brown Fat Research Agreement With University of Utah
Date:6/21/2012

JUPITER, Fla., June 21, 2012 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCQB: BRTX), a life sciences company focused on cellular therapies for various personal medical applications, announced today that it has entered into a Research Agreement with the University of Utah ("University").  Pursuant to the agreement, the University is to provide research services relating to the identification of brown fat tissue and the development and characterization of brown fat cell lines. 

Pursuant to the terms of the Research Agreement, all inventions, discoveries, patent rights, information, data, methods and techniques, including all cell lines, cell culture media and derivatives thereof, shall be owned by BRT.

The research and development that will be performed at the University, under the supervision of Dr. Amit Patel, will be used for the eventual filing of an IND with the FDA for a Phase 1 clinical trial.

The agreement was entered into in connection with the Company's ThermoStem™ Program, which focuses on treatments for metabolic disorders, such as diabetes and heart disease, and obesity. The ThermoStem™ Program employs the use of brown fat, which initial research indicates has a role in maintaining metabolism and provides the potential for a cell based therapeutic for the treatment of diabetes.

Mark Weinreb, Chief Executive Officer of the Company, stated, "This agreement marks a significant milestone for our ThermoStem™ Program.  All ongoing pre-clinical work, brown fat data and future research for the foreseeable future is now defined and contemplated through this agreement.  It provides a roadmap for potential publications, grants, and ultimately, clinical trials, so that we may start testing for a brown fat stem cell-based approach to treat certain metabolic disorders and obesity."

About BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc.'s (
'/>"/>

SOURCE BioRestorative Therapies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioRestorative Therapies Announces Next Generation of Stem Cell Disc Delivery Device
2. BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
3. BioRestorative Therapies Obtains $2.1 Million in 2012 Private Financing
4. BioRestorative Therapies Retains KCSA Strategic Communications as Investor Relations Counsel
5. BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
6. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
7. CNIO researchers describe a new target for developing anti-angiogenic and anti-tumoral therapies
8. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
9. Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy
10. Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimers Research Group at University of California Irvine to Test First in Class Dual Target Vaccine
11. Two Top Biological Imaging Centers Offer Powerful Free Online Tool to Researchers, Educators, and Public
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... PA (PRWEB) July 22, 2014 Two ... Center’s Board of Directors at its annual Shareholders Meeting ... Chief Information Officer of The PFM Group, and Stephen ... Science Center also announced the election of Michael A. ... Board Vice Chair and Richard P. Jaffe, Esq., of ...
(Date:7/22/2014)... , Cina, 22 luglio 2014 BGI ... BGI, la maggiore organizzazione di genomica del mondo, ha ... sequenziamento dell,intero esoma umano con base la piattaforma leader ... Genomics, molto apprezzata nel settore per essere in grado ... di precisione e una rilevazione altamente sensibile di tutti ...
(Date:7/22/2014)... 2014 In chemical and petrochemical ... common sight. The rapid rise of TDL analyzers ... established as a core gas measurement technology, and ... them the gas analyzer technology of choice for ... in some processes have limited their application range. ...
(Date:7/22/2014)... SPRING, Md. , July 22, 2014 /PRNewswire/ ... announced today that it will release its second ... Tuesday, July 29, 2014. United Therapeutics ... 29, 2014, at 9:00 a.m. Eastern Time.  The ... callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
Breaking Biology Technology:Two New Members Elected to University City Science Center Board of Directors 2Two New Members Elected to University City Science Center Board of Directors 3BGI Tech lancia un servizio di sequenziamento dell'intero esoma umano sulla piattaforma avanzata di Complete Genomics 2METTLER TOLEDO Shows How Tunable Diode Lasers (TDLs) Can Be Installed Where No TDLs Have Gone Before 2
... May 24, 2011 Benefiting from recent investments in production ... just reported another record quarter. The leading developer of topical ... up 126 percent over Q1 of 2010. It was the ... year ago. "Although Q1 delivered a stellar ...
... 2011 Radius Health, Inc. ("Radius") today announced that ... third financing round, including $66 million in equity financing ... and Oxford Finance LLC to a $25 million multi-draw ... AG, Brookside Capital, Saints Capital, Nordic Bioscience ("Nordic"), and ...
... A protein isolated from beneficial bacteria found in yogurt ... option for inflammatory bowel disorders (IBD), suggests a study ... M.D., Ph.D. The study, published May 23 in ... the protein, called p40, was effective as an intervention ...
Cached Biology Technology:First-quarter 2011 Sales Reach $2.25M — 126% Growth Over Q1 of 2010 — for Biotech Developer Divine Skin 2First-quarter 2011 Sales Reach $2.25M — 126% Growth Over Q1 of 2010 — for Biotech Developer Divine Skin 3Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study 2Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study 3Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study 4Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study 5Protein from probiotic bacteria may alleviate inflammatory bowel disorders 2Protein from probiotic bacteria may alleviate inflammatory bowel disorders 3
(Date:7/22/2014)... box and you,re likely to find that the lunches and ... findings of a study conducted by researchers at the Friedman ... in the Department of Public Health and Community Medicine at ... online ahead of print in the Journal of the ... senior author Jeanne Goldberg, Ph.D., R.D., a professor at the ...
(Date:7/22/2014)... 22, 2014, Cleveland: A type of immune cell ... such as Alzheimer,s disease and multiple sclerosis (MS), ... injury (TBI) and may slow the progression of ... today in the online journal Nature Communications ... Trapp, PhD, Chair of the Department of Neurosciences ...
(Date:7/21/2014)... Middle East Respiratory Syndrome coronavirus (MERS-CoV) in the air ... virus. The work, published this week in mBio ... for Microbiology, indicates that further studies are needed to ... air. , MERS, a serious viral respiratory illness caused ... as of June 11, according to the World Health ...
Breaking Biology News(10 mins):Room for improvement in elementary school children's lunches and snacks from home 2Cleveland Clinic researchers discover neuroprotective role of immune cell 2Middle East Respiratory Syndrome coronavirus detected in the air of a Saudi Arabian camel barn 2
... complaint against British drug maker GlaxoSmithKline (GSK) over its ... proceed following an order late last week by South ... go forward. GSK has sought outright dismissal of the ... week giving the complainants, AIDS Healthcare Foundation (AHF) and ...
... apples might do a better job of keeping the ... analyzed eight popular varieties of the fruit. Red Delicious, ... greater wallop of disease-fighting antioxidants than other apples studied. ... Agriculture and Agri-Food Canada in Guelph, Ontario, also pinpointed ...
... of an anti-inflammatory drug eliminated all of the cancer-causing ... when several genetic brakes to cancer formation were missing ... Cancer Center. , The investigators, who presented their findings ... for Cancer Research, say that while the results do ...
Cached Biology News:South African Tribunal Asks For Damages Estimates in GSK AIDS Drug Case 2Red delicious, Northern Spy apples have most antioxidants, chemists find 2NSAID drug protects against intestinal tumors in mice, despite poor diet and gene losses 2NSAID drug protects against intestinal tumors in mice, despite poor diet and gene losses 3
... muscle cell specific protein, is reported to be ... as intestine, lung and uterus. It shares structural ... expression has been reported in most tissues that ... forms. It is also reported to be expressed ...
PC based system for superior chemifluorescent, chemiluminescent, fluorescent and colorimetric, microarray and microscope imaging and analysis....
Request Info...
... Round Well Plate Sterile ... wide range of 384-well ... high-throughput screening and research. ... assays and are suitable ...
Biology Products: